September 27, 2022
5 min watch
Save
VIDEO: New implant reduces IOP with no anterior chamber penetration
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
MILAN — During iNovation Day at the ESCRS meeting, Philippe Sourdille, MD, presented the Cilio-scleral Inter-positioning Device from Ciliatech for the surgical treatment of glaucoma.
For the first time, a minimally invasive implant effectively reduces IOP without penetrating the anterior chamber or creating subconjunctival filtration. After 1 year, IOP is down by 33%, and 89% of patients with primary open-angle glaucoma are medication-free. Comparable efficacy has been shown in angle-closure glaucoma.
Published by:
Sources/Disclosures
Collapse
Source:
Sourdille P. 3 glaucoma emerging technology presentations — Ciliatech. Presented at: European Society of Cataract and Refractive Surgeons meeting; Sept. 16-20, 2022; Milan.
Disclosures:
Sourdille reports being the inventor of the Cilio-scleral Inter-positioning Device and a shareholder of Ciliatech.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.